Kurt Schultz

The envelopes are open. At @YaleMed, the M.D. Class of 2026 just learned where they’ll begin the next chapter of their journeys in medicine. Inside Harkness Hall, students shared the moment with classmates, families, faculty, and mentors who have been part of the path to this day. ➡️ ➡️ ➡️ Swipe to see where they’re headed next.

Congratulations to Drs. @BillingsleyMd, @sajkhanmd, @pathik_aravind, and the entire surgical team involved in the first #RoboticHepaticArterialPump placement at Yale and in the state of #Connecticut. A tremendous accomplishment! yalemedicine.org/departments/he… @SmilowCancer @YaleGICancers @YNHH

We are pleased to announce the winner of the Ethics Committee’s Annual Essay Challenge for the 2026 Essay Festival, which featured the theme “Living Your Values.” Please join us in congratulating Dr. Christopher Noda and co-author Dr. Katie Rowland! Read their award-winning essay, “I Am Here to Spend Time with You,” aasurg.org/congratulation…

.@princygupta19 shows how mass-based response testing (MRT) can guide treatment decisions in peritoneal metastases by identifying patients likely to resist therapy. Tumors flagged as resistant by MRT were strongly linked to progression. #SSO2026 @SmilowCancer @SocSurgOnc @OncoAlert @kturaga @YaleGICancers

.@kturaga reflects on the dedication and team behind the new consensus guidelines for peritoneal mesothelioma: “Now we have a way—we’re connected, advancing care, and doing what’s right for our patients. This consensus platform will help move the field forward.” #SSO2026 @SocSurgOnc @SmilowCancer @YaleMed

.@kturaga joined the @SocSurgOnc podcast #SurgOncToday to discuss the newly endorsed guidelines from the Yale Peritoneal Surface Malignancy Consortium. #PSM surgonctoday.libsyn.com/sso-education-… @SmilowCancer @YaleGICancers

Congratulations to John Kunstman, MD, MHS, recipient of the @YaleCancer Clinical Excellence Award by @kturaga. Dr. Kunstman is a surgical oncologist specializing in the care of patients with cancers or benign diseases of the pancreas, liver, bile ducts, stomach, and intestines. @SmilowCancer @YaleSurgery

New research from @YaleGICancers led by @princygupta19 @kturaga on early-onset appendiceal cancer shows ⬆️ rates of PIK3CA mutations which are associated with worse survival. Findings point to new opportunities for molecular risk stratification and targeted therapy. ascopubs.org/doi/10.1200/PO… @JCOPO_ASCO @JSheltzer @sundar__raghav @Cecchini_OncMD @ElizLGodfreyMD @SchultzKurt @sbutensky @ArdamanShergil1

Congratulations to "Dr." Dr. Megan Baker (@meganlebaker) on successfully defending her PhD through the Investigative Medicine Program yesterday! 🎉🎓 So proud of this accomplishment - Yale Nephrology showed up in full force to fill Fitkin Auditorium and cheer her on! 🥂

The Office of Health Equity Research announced the recipients and finalists of the '25 OHER Awards for Yale Research Excellence, which recognizes outstanding contributions to research aimed at improving health equity & addressing health disparities. Read➡️medicine.yale.edu/internal-medic…

Important work by @AlissaGreenbaum et al. on caregiver burden, regret, QoL in #AppendicealCancer #CRSHIPEC. Grateful to @acpmpresearch patients who make this work possible. Complementary efforts by @ElizLGodfreyMD @GreenupRachel @kturaga. Stay tuned! youtube.com/watch?v=2tNH8Y…

February Issue: Decision Regret and Burden in Caregivers of Patients with #AppendicealCancer Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy ( #CRSHIPEC ) @AlissaGreenbaum rdcu.be/e4Nov @SchultzKurt @SyedAAhmad5 @SocSurgOnc

Methods corner: multivariable adjustment ≠ causal effects Do you know about Table 2 fallacy? 🤔Misinterprets adjusted covariates as causal effects 📊1 of 5 studies in high-impact surgery journals ⚠️Risk of distorted clinical inference Learn more tinyurl.com/4ydaaktp

New research from @kturaga @YaleGICancers shows how in #colorectalcancer with peritoneal metastases, CMS4 tumors have unique drug sensitivities, highlighting the need for subtype-guided personalized #HIPEC strategies. link.springer.com/article/10.124… @SmilowCancer @AnnSurgOncol @princygupta19 @JSheltzer @sundar__raghav @Cecchini_OncMD @ElizLGodfreyMD @SchultzKurt

Appreciate this measured commentary from @DrZacharyJBrown on the potential role of #PIPAC across #PSM histologies. Important work remains in this space.

From the January Issue of @AnnSurgOncol: Editorial: Defining the Role of Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) @DrZacharyJBrown rdcu.be/eXGNp @SchultzKurt @SyedAAhmad5

January Issue: Editorial: Defining the Role of Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) @DrZacharyJBrown rdcu.be/eXGNp @SchultzKurt @SyedAAhmad5 @SocSurgOnc

Insightful Thread from Dr. @PatricioPolanc0 on IPMNs and prognostic utility of NGS Great read for all lovers of the pancreas and trainees @MVentinMD @CarstenT94 @AndrewFlemingMD @med_trisha @SchultzKurt @FemiSuraju Great articles from @GilbertZMurimwa & @amudhan_kannan!!

Thank you @SurgJournal @SWexner for the opportunity to write a commentary on recent work by @SchultzKurt @IraLeeds_MD & colleagues evaluating health-related social needs and postsurgical outcomes @melissarjusto @MahrokhiSona @rkroppmd Read here 👇 surgjournal.com/article/S0039-…

What a day for our amazing program! Four peat champions of MA-ACS Top Gun skills and also Champion of Survivor (medical knowledge). Congrats to Drs. Kalipatnapu, Dore, Walter, and Padilha and Coach Extraordinaire Dr. Czerniach. We are so proud!